Iptacopan hydrochloride by Novartis for Granulomatosis with Polyangiitis (Wegener’s Granulomatosis): Likelihood of Approval

In Jan­u­ary, Prax­is priced a $150 mil­lion pub­lic stock of­fer­ing and promised four da­ta read­outs. And on Tues­day morn­ing, the first topline da­ta dropped in

Artificial intelligence-supported mammography resulted in a cancer detection rate comparable to that of two breast radiologists working together, while also substantially cutting screening workload. Among